Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated ...
Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...
MedPage Today on MSN
Double-Action Lupus Drug Looks Good in Phase III Trial
A novel drug for systemic lupus erythematosus (SLE) first developed in China, and approved there since 2021, did well enough in a new placebo-controlled phase III trial that approval in Western ...
Researchers at The University of Osaka have discovered precursor T follicular regulatory cells (preTfr), comprising 30-50% of ...
Windsor’s plasma donation clinic will soon also be open for blood donations, Canadian Blood Services (CBS) says, more than ...
Tragic RSV vaccine trials in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in RSV immunization ...
SHANGHAI, NANJING, China and PLEASANTON, Calif., Oct. 16, 2025 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a ...
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today ...
Ahead of the 2025 European AIDS Conference in Paris, researchers discovered a new antibody against HIV. They say it can ...
The authors describe an interesting approach to studying the dynamics and function of membrane proteins in different lipid environments. The important findings have theoretical and practical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback